APGE R&D Expenses
Apogee Therapeutics Inc · R&D Expenses
APGE R&D Expenses
Latest reported$240.74Mperiod ending
APGE TTM R&D Expenses ($27.79M → $240.74M)
TTM R&D Expenses
High-resolution chart · PNG
APGE r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 240,742,000 | |
| 229,144,000 | |
| 214,712,000 | |
| 216,497,000 | |
| 208,033,000 | |
| 185,536,000 | |
| 167,865,000 | |
| 136,590,000 | |
| 107,945,000 | |
| 88,685,000 | |
| 68,424,000 | |
| 51,678,000 | |
| 44,494,000 | |
| 31,996,000 | |
| 27,786,000 |